NovaBridge Biosciences Statistics
NASDAQ: NBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.370.00 (0.00%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NovaBridge Biosciences by the numbers
NovaBridge Biosciences has a market capitalization of $158.9 million based on 116.00M shares outstanding. With trailing EPS of $-0.69, NovaBridge Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.3% below its 50-day average and 43.4% below its 200-day average.
Average daily trading volume is 387.00K shares, or about $530,185 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NBP valuation vs. peer median
| Metric | NBP | Peer median | Difference |
|---|---|---|---|
| Market cap | $158.92M | $162.69M | -2% |
| Avg. volume | 387.00K | 684.81K | -43% |
Peer median across 8 companies: EMIS, CUE, ALXO, MENS, NKTX, PEPG, ORGO, CNTN.
Valuation
- Market cap
- $158.92M
- EPS (TTM)
- $-0.69
- Shares outstanding
- 116.00M
Price and trading
- Previous close
- 1.37
- Open
- 1.37
- Day range
- 1.34 – 1.38
- 52-week range
- 1.31 – 6.79
- 52-week change
- -68.65%
- Beta
- —
- Volume
- 249.66K
- Average volume
- 387.00K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 20, 2026
Additional statistics
- Market Cap
- 158.92M
- Forward Pe
- -1.29
- Eps
- -0.69
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.79
- Week52 Low
- 1.31
- Avg Volume
- 387.00K
- Shares Outstanding
- 116.00M
- Ma50
- 1.68
- Ma200
- 2.42
- Earnings Date
- Aug 20, 2026
- Pct From52w High
- -79.82%
- Pct From52w Low
- 4.58%